We are live on ! Find out more
VNA

Valley National Advisers Portfolio holdings

AUM $900M
1-Year Est. Return 31.19%
This Fund
S&P 500
This Quarter Est. Return
-3.43%
1 Year Est. Return
+31.19%
3 Year Est. Return
+79.01%
5 Year Est. Return
+84.11%
10 Year Est. Return
+235%
AUM
$522M
AUM Growth
-$19.9M
Cap. Flow
+$3.79M
Cap. Flow %
0.73%
Top 10 Hldgs %
33.96%
Holding
1,023
New
50
Increased
223
Reduced
151
Closed
48

Sector Composition

Rank Sector Weight
1 Technology 13.72%
2 Financials 10%
3 Healthcare 9.84%
4 Industrials 6.51%
5 Communication Services 4.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DIS icon
26
Walt Disney
DIS
$181B
$3.85M 0.74%
28,048
+80
+0.3% +$11.6K
NVO
27
Novo Nordisk
NVO
$209B
$3.71M 0.71%
66,720
MSM icon
28
MSC Industrial Direct
MSM
$6.86B
$3.64M 0.7%
42,739
+11,375
+36% +$921K
EMN icon
29
Eastman Chemical
EMN
$8.42B
$3.56M 0.68%
31,753
+7,232
+29% +$847K
BOND icon
30
PIMCO Active Bond Exchange-Traded Fund
BOND
$8.47B
$3.55M 0.68%
34,850
-36,018
-51% -$3.79M
BDX icon
31
Becton Dickinson
BDX
$48.2B
$3.46M 0.66%
13,337
+10
+0.1% +$2.58K
STOT icon
32
State Street DoubleLine Short Duration Total Return Tactical ETF
STOT
$507M
$3.43M 0.66%
72,001
-10,386
-13% -$501K
BRK.B icon
33
Berkshire Hathaway Class B
BRK.B
$1.13T
$3.41M 0.65%
9,662
+28
+0.3% +$9.06K
TFC icon
34
Truist Financial
TFC
$64B
$3.37M 0.65%
59,423
-10
-0% -$618
CVX icon
35
Chevron
CVX
$366B
$3.32M 0.64%
20,363
+592
+3% +$84.9K
CVS icon
36
CVS Health
CVS
$122B
$3.3M 0.63%
32,614
+304
+0.9% +$31.9K
LRCX icon
37
Lam Research
LRCX
$390B
$3.24M 0.62%
60,270
+27,150
+82% +$1.58M
LDUR icon
38
PIMCO Enhanced Low Duration Active Exchange-Traded Fund
LDUR
$1.37B
$3.17M 0.61%
32,559
+27,452
+538% +$2.73M
XOM icon
39
ExxonMobil
XOM
$634B
$3.15M 0.6%
38,088
-1,518
-4% -$118K
NEAR icon
40
iShares Short Maturity Bond ETF
NEAR
$4.85B
$3.12M 0.6%
62,867
+3,178
+5% +$158K
FNDX icon
41
Schwab Fundamental US Large Company Index ETF
FNDX
$27.3B
$3.03M 0.58%
155,478
+22,284
+17% +$429K
MCD icon
42
McDonald's
MCD
$195B
$3.03M 0.58%
12,254
-379
-3% -$94.4K
HBAN icon
43
Huntington Bancshares
HBAN
$35.5B
$3.03M 0.58%
207,025
+58,194
+39% +$911K
PEP icon
44
PepsiCo
PEP
$190B
$3.01M 0.58%
17,968
-229
-1% -$38.4K
EMR icon
45
Emerson Electric
EMR
$88.3B
$2.95M 0.56%
30,045
-102
-0.3% -$9.66K
CMA
46
DELISTED
Comerica
CMA
$2.81M 0.54%
31,055
UNH icon
47
UnitedHealth
UNH
$370B
$2.8M 0.54%
5,491
-5
-0.1% -$2.41K
JPM icon
48
JPMorgan Chase
JPM
$950B
$2.65M 0.51%
19,465
+561
+3% +$82.8K
CSCO icon
49
Cisco
CSCO
$479B
$2.53M 0.48%
45,378
+839
+2% +$47.5K
FTS icon
50
Fortis
FTS
$28.7B
$2.52M 0.48%
50,839
+48,595
+2,166% +$2.28M

Similar funds

Valley National Advisers's Q1 2022 Portfolio in Review

As of Q1 2022, Valley National Advisers held 1,023 positions worth $522M, down 3.7% from $542M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Valley National Advisers's Q1 2022 filing shows 50 new, 223 increased, 151 reduced and 48 closed positions. Its largest new stake was Fidelity Total Bond ETF: 35,531 shares worth $1.77M. The largest sale was State Street DoubleLine Total Return Tactical ETF, an estimated $6.08M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.

  • Valley National Advisers's largest Q1 2022 buy was Fidelity Total Bond ETF: 35,531 shares worth $1.77M.
  • Valley National Advisers added most to T. Rowe Price in Q1 2022, an estimated $4.85M increase.
  • Valley National Advisers's biggest Q1 2022 reduction was State Street DoubleLine Total Return Tactical ETF, cutting an estimated $6.08M.
  • Valley National Advisers fully exited iShares US Aerospace & Defense ETF in Q1 2022, selling an estimated $341K.
  • Valley National Advisers's ten largest holdings make up 34% of its $522M portfolio in Q1 2022.
  • Valley National Advisers opened 50 new positions and closed 48 in Q1 2022.
  • Valley National Advisers's portfolio value fell 3.7% quarter-over-quarter to $522M.

Based on Valley National Advisers's 13F filing for Q1 2022, filed 6 May 2022.